Sun Pharma plans to raise Rs 12,000 crore via QIP

07 Oct 2015 Evaluate

Sun Pharmaceutical Industries is planning to raise up to Rs 12,000 crore through convertible debentures or a qualified institutional placement (QIP). In this regard, the company is seeking shareholder approval.

The company will use the raised fund for expansion and acquisitions. The company would allow it to strengthen its financial resources and net worth. Following the merger with Ranbaxy Pharmaceuticals, the company has been restructuring its business and rationalizing its manufacturing footprint.

Sun Pharma is the fifth largest specialty generic pharmaceutical company in the world. The company provides high quality, affordable medicines trusted by healthcare professionals and patients in over 150 countries worldwide.

Sun Pharma Inds. Share Price

1720.40 0.65 (0.04%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×